|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 234.10 EUR | +0.56% |
|
+1.25% | -1.89% |
| 05-07 | UCB: New partnership with Cancer Research UK and Cancer Research Horizons | RE |
| 05-04 | Health Care Down Ahead of Earnings - Health Care Roundup | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 52.45B | |||||
| 72.73B | |||||
| 46.63B | |||||
| 42.13B | |||||
| 28.56B | |||||
| 21.57B | - |
- Stock Market
- Equities
- UCB Stock
- Charts UCB
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition